Advik Laboratories Ltd.
BSE: 531686 | Sector: Health care |
NSE: N.A. | ISIN Code: INE537C01019 |
BSE 00:00 | 09 May | 1.52 |
0 (0.00%) |
OPEN
1.52 |
HIGH
1.52 |
LOW
1.52 |
NSE 05:30 | 01 Jan | Advik Laboratories Ltd Not listed in NSE |
OPEN | 1.52 |
PREVIOUS CLOSE | 1.52 |
VOLUME | 774 |
52-Week high | 1.52 |
52-Week low | 1.01 |
P/E | |
Mkt Cap.(Rs cr) | 3 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Advik Laboratories Ltd.
Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical generic and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic antipyretic and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfu...> More
Advik Laboratories Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
3 | |
EPS - TTM | (![]() |
[*S] | - |
P/E Ratio | (X) | [*S] | - |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 1.92 |
P/B Ratio | (![]() |
[*S] | 0.79 |
Announcement
-
Outcome Of Meeting Of Board Of Directors Pursuant To Reg. 30 Of The SEBI (Listing Obligations And Di
-
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Reg. 30 Of The SEBI (
-
Submission Of Compliance Certificate Pursuant To Regulation 40 (9) Of The Securities And Exchange Bo
-
Submission Of Compliance Certificate Pursuant To Regulation 40 (9) Of The Securities And Exchange Bo
-
CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS) REGU
-
Submission Of Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Boar
Advik Laboratories Ltd - Financial Results
Particulars (![]() |
Dec 2021 | Dec 2020 | % Chg |
Net Sales | 0.03 | - | |
Other Income | - | ||
Total Income | 0.03 | - | |
Total Expenses | 0.2 | 3.62 | -94.48 |
Operating Profit | -0.16 | -3.61 | 95.57 |
Net Profit | -0.27 | -3.73 | 92.76 |
Equity Capital | 19.11 | 19.11 | - |
Advik Laboratories Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Beryl Drugs | 9.00 | -2.17 | 4.56 |
Unjha Formul. | 10.07 | -5.00 | 4.51 |
Hind.Bio Science | 3.71 | 2.77 | 3.80 |
Bacil Pharma | 4.16 | 3.23 | 2.45 |
Kabra Drugs | 3.56 | 4.40 | 1.56 |
Raymed Labs | 1.65 | 0.00 | 0.70 |
Advik Laboratories Ltd - SHAREHOLDING PATTERN
|
|
Advik Laboratories Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 0.00% | NA | -2.75% | -2.82% |
1 Month | NA | NA | -9.20% | -9.35% |
3 Month | NA | NA | -8.66% | -8.54% |
6 Month | NA | NA | -12.18% | -11.98% |
1 Year | NA | NA | 8.70% | 7.93% |
3 Year | -17.84% | NA | 41.67% | 40.73% |
Advik Laboratories Ltd - STOCK STRENGTH
Today's Low/High | 1.52 | 1.52 | |
Week Low/High | 1.52 | 2.00 | |
Month Low/High | 1.45 | 2.00 | |
YEAR Low/High | 1.01 | 2.00 | |
All TIME Low/High | 0.32 | 53.00 |
Quick Links for Advik Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices